Skip to main content

Brain Aneurysm Treatment Market is Gaining at a Profitable CAGR of 5.4% During Forecast to 2023


Market Overview:
Brain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall. Over time, blood flow within the artery starts pushing the thin portion of the wall and ruptures it. The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH). This kind of hemorrhage may lead to coma, stroke, and/or death. There are number of factors that contribute to the occurrence of brain aneurysms, such as cigarette smoking, injury or trauma, blood infections, and many others. Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.
 The global Brain Aneurysm Treatment Market Share is expected to grow at a compound annual rate of 5.4% during the forecast period between 2017 and 2023.
Market Research Future (MRFR) asserts in its report that the global market is influenced by various key factors. This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector. Also, the presence of brain aneurysm in the family is another key driver of the market.
                                    

Market Research Future (MRFR) asserts in its report that the global market is influenced by various key factors. This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector. Also, the presence of brain aneurysm in the family is another key driver of the market.

Competitive Landscape:
·         Codman & Shurtleff
·         Medtronic Plc
·         Orsan Medical Technologies
·         Head Sense Medical
·         InfraScan
·         MicroPort Scientific Corporation
·         Raumedic AG
·         HaiWeiKang
·         Johnson & Johnson
·         Spiegelberg GmbH

Market Segmentation:
·         The brain aneurysm treatment market segmentation is based in terms of condition, type, and end-user.
·         By type, the market divides into medication and surgery.
·         The surgery segment narrows down further into endovascular coiling, surgical clipping, flow diverter, and others. The flow diverter segment breaks down into silk flow diverter (SILK), pipeline embolization device, and surpass flow diverter (SURPASS).
·         The medication segment comprises calcium channel blockers, anti-seizure medications, antacids, antiemetics, analgesics, antihypertensives, stool softeners, and others.
·         By end-user, the market includes clinics, hospital, and others.
·         By condition, the market divides into ruptured and unruptured aneurysm.

Regional Analysis:
The global brain aneurysm treatment market is geographically segmented into major regions like Asia Pacific, Europe, the Americas, and the Middle East & Africa.
The Americas hold the dominant share of the global aneurysm treatment market and is expected to grow significantly in the forthcoming years. The growth of the region is attributed to the increasing prevalence of brain aneurysm.
The European region holds the second largest share of the market for brain aneurysm. The region’s growth is proliferated by the support provided by the government for research and development and for the improvement of reimbursement policies in healthcare. Also, cerebrovascular conditions are also seemingly prevalent in this region, which is also aiding the growth herein.
The Asia Pacific region is positioned as one of the key players in the global brain aneurysm treatment landscape. It is expected to hold the potential to be the fastest growing region among the mentioned names. The surging growth and expansion of the region can be owed to the massive patient population and the ameliorating healthcare technology.
The Middle East & Africa regions holds the least share in the brain aneurysm treatment market owing to the lack of proper availability of medical facilities. However, the decent growth market in this region is driven by some of the most advancing countries in the Middle East, including Saudi Arabia, the UAE, and Kuwait. While, the African region is expected to garner moderate growth rate.
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.


Comments

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...